Showing results (331-340 of 612) with videos related to
Sort By:
Pageof 62
Genome Biology|June 16, 2026
Ensilication preserves high-molecular weight native DNA for clinical long-read sequencingAlexis Ferrasse, Rodrigo Mendez, John E Gorzynski, et al.Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|December 12, 2023
Patient outcomes associated with subcutaneous C1INH prophylaxis for hereditary angioedema: a retrospective analysisWilliam Lumry, Timothy Craig, John Anderson, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 24, 2020
Long-term safety and efficacy of subcutaneous C1-inhibitor in older patients with hereditary angioedemaJonathan A Bernstein, Lawrence Schwartz, William Yang, et al.Pediatrics|December 13, 2016
Management of Children With Hereditary Angioedema Due to C1 Inhibitor DeficiencyMichael M Frank, Bruce Zuraw, Aleena Banerji, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 5, 2024
The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted onesJohn J Mulvihill, Laura Findley, Weihong Ni, et al.Therapeutic Advances in Respiratory Disease|September 5, 2024
Content validity of the Leicester Cough Questionnaire in adults with refractory or unexplained chronic cough: a qualitative interview studyAllison Martin Nguyen, Carmen La Rosa, Alexandra G Cornell, et al.Frontiers in Immunology|September 21, 2023
Clinical severity classes in COVID-19 pneumonia have distinct immunological profiles, facilitating risk stratification by machine learningLaura Wiffen, Leon Gerard D'Cruz, Thomas Brown, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 26, 2015
Significant predictors of poor quality of life in older asthmaticsJennifer A Kannan, David I Bernstein, Cheryl K Bernstein, et al.The Journal of Allergy and Clinical Immunology|February 16, 2025
Tezepelumab for the treatment of chronic spontaneous urticaria: Results of the phase 2b INCEPTION studyJulie McLaren, Yun Chon, Kevin S Gorski, et al.Allergy and Asthma Proceedings|December 10, 2016
Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedemaMarc A Riedl, William R Lumry, H Henry Li, et al.Pageof 62